missing translation for 'onlineSavingsMsg'
Learn More

MP Biomedicals Rapid SARS-CoV-2/Influenza A+B Antigen Duo Test Card

SARS-CoV-2 Ag+Flu A/Flu B Rapid Test is a one-step in vitro test based on immunochromatography.

Brand:  MP Biomedicals 07AG6020FL

Product Code. 30280603

  • 51.23 € / 1 set

Please to purchase this item. Need a web account? Register with us today!

Explore more special offers
This item is not returnable. View return policy

Description

Description

  • Rapid SARS-CoV-2/Influenza A+B Antigen Duo Test Card is an immunochromatographic lateral flow device that employs the principle of double antibody sandwich method.
  • Anti-SARS-CoV-2, anti-influenza A and anti-influenza B antibodies are immobilized on the nitrocellulose membrane respectively, as three individual test lines (CoV line, Flu A line and Flu B line) in the test window of the test device.
  • When the specimen is added, it migrates by capillary diffusion through the strip to re-hydrate the gold conjugate complexes.
  • If present at or above the limit of detection, viral antigens will react with the gold conjugate complexes to form particles, which will continue to migrate along the strip until the Test Zone (T) where they are captured by the immobilized anti-SARS-CoV-2 or anti-influenza A or anti-influenza B antibodies to form a visible red line, which indicates positive test results.
  • Absence of this colored band in the test window indicates a negative test result.
  • The gold conjugate complexes will continue to migrate alone until being captured by immobilized antibody in the Control Zone (C) to form a red line, which indicates the validity of the test.
  • CE marked
  • For professional use only
  • Accurate Result within 15 to 20 minutes
  • One-step procedure
  • No equipment needed
  • No cross-reaction
  • High sensitivity, specificity, and accuracy
  • This test is only to be used by professional medical staff, not for home testing. It cannot be used alone as the basis for the diagnosis and exclusion of cases.
Specifications

Specifications

Self-declared
SARS-CoV-2, Influenza A and Influenza B Nucleoprotein Antigens
No
Human nasal swabs, Human nasopharyngeal swabs, Human oropharyngeal swabs
Rapid Test
Rapid and qualitative determination of SARS-CoV-2, Influenza type A and type B viral antigen in nasal swabs, nasopharyngeal swabs or oropharyngeal swabs
Ready-to-Use (RTU)
Not Applicable
Immunochromatographic lateral flow
Test card
SARS-CoV-2: 1.3 x 102 TCID{50}/mL, Influenza A: 1.78 x 102 TCID{50}/mL, Influenza B: 1.17 x 103 TCID{50}/mL
Single-use
SARS-CoV-2: 99.16% (95% CI: 98.49% ~ 99.83%) Influenza A: 98.69% (95% CI: 97.42% ~ 99.97%) Influenza B: 99.37% (95% CI: 98.50% ~ 100%)
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Product Certifications
Special Offers

Special Offers

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title
MP Biomedicals Rapid SARS-CoV-2/Influenza A+B Antigen Duo Test Card > SARS-CoV-2 and Ifnluence Duo

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.